Journals / Türk Nöroloji Dergisi / 2021 / Cilt: 27 - Sayı: 3

Current Overview of Idiopathic Intracranial Hypertension

İdyopatik İntrakraniyal Hipertansiyona Yaklaşımda Güncel Bakış

Pages
219–228
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review aimed to evaluate IIH treatment options using current approaches and help physicians in the decision-making process.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH), is an increment in the intracranial pressure without identifiable causal factors.
📊
Key Findings & Data:With the increase in clinical experience, the aim is to prevent the risk of developing irreversible complications in patients using different treatments, which have recently been developed.
💡
Conclusion & Impact:This review aimed to evaluate IIH treatment options using current approaches and help physicians in the decision-making process.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH), is an increment in the intracranial pressure without identifiable causal factors. The disorder is frequently seen in obese women of childbearing age. Due to both permanent vision loss and higher risk of recurrence than previously thought, patients with IIH should be followed closely using a multidisciplinary approach. IIH treatment should be arranged considering the severity of headache and papilledema, presence of vision loss, response to medical treatment, and comorbid conditions, with individual planning for each patient. In patients where weight loss and acetazolamide are insufficient for symptoms’ resolution, other medical and surgical treatment options should be evaluated rapidly. Because the pathogenesis of IIH is not fully known, treatment options support different theories. With the increase in clinical experience, the aim is to prevent the risk of developing irreversible complications in patients using different treatments, which have recently been developed. This review aimed to evaluate IIH treatment options using current approaches and help physicians in the decision-making process.

Özet

Sıklıkla doğurganlık çağındaki obez kadınlarda görülen, “psödotümör serebri” ya da diğer adıyla “idyopatik intrakraniyal hipertansiyon (İİH)” tanımlanabilir nedensel faktörler olmaksızın görülen intrakraniyal basınç artışıdır. Hem kalıcı görme kaybı hem de sanılandan yüksek nüks riski nedeniyle İİH’li hastalar multidispliner bir yaklaşımla, uzun süre yakından takip edilmelidir. Her hasta için yapılacak bireye özgü planlama ile baş ağrısı ve papilödemin şiddeti, görme kaybının varlığı, tıbbi tedaviye alınan yanıt ve komorbid durumlar göz önünde bulundurularak İİH tedavisi düzenlenmelidir. Kilo verme ve asetozolamid ile yeterli fayda görülemediği durumlarda hızla diğer medikal ve izleyen dönemde cerrahi tedavi seçenekleri değerlendirilmelidir. İİH’nin patogenezi tam olarak bilinmediği için, farklı teorileri destekleyen tedavi seçenekleri mevcuttur. Yeni gelişen ve klinik deneyimin son yıllarda arttığı farklı tedaviler ile hastalarda kalıcı komplikasyonların gelişme riskinin önüne geçilmeye çalışılmaktadır. Bu derlemenin amacı İİH tedavisindeki seçeneklerin güncel yaklaşımlar ile değerlendirilmesi ve klinisyene karar verme sürecinde yardımcı olabilmesidir.

🔖

Cite This Article

BAYIR, B. R. H., BAYKAN, B., ÇELEBİSOY, N. (2022). Current Overview of Idiopathic Intracranial Hypertension. Türk Nöroloji Dergisi, Cilt: 27 - Sayı: 3, 219–228. https://ajindex.com/articles/636541

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159-1165
  2. Yunisova G, Güngör I, Kocasoy Orhan E, Baykan B. Stabbing headache as the presenting symptom of idiopathic intracranial hypertension. Headache 2017;57:1152-1153
  3. Mollan SP, Ali F, Hassan-Smith G, et al. Evolving evidence in adult idiopathic intracranial hypertension: Pathophysiology and management. J Neurol Neurosurg Psychiatry 2016;87:982-992
  4. Ekizoglu E, Baykan B, Orhan EK, Ertas M. The analysis of allodynia in patients with idiopathic intracranial hypertension. Cephalalgia 2012;32:1049-1058
  5. Toscano S, Lo Fermo S, Reggio E, et al. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol 2021;268:3249-3268
  6. Boddu S, Dinkin M, Suurna M, et al. Resolution of pulsatile tinnitus after venous sinus stenting in patients with Idiopathic Intracranial Hypertension. PLoS One 2016;11:e0164466
  7. Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial clinical profile at baseline. JAMA Neurol 2014;71:693-701
  8. Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol 2015;35:31-36
  9. Wall M, Falardeau J, Fletcher WA, et al. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurol 2015;85:799- 805
  10. Thurtell MJ. Idiopathic intracranial hypertension. Continuum (Minneap Minn) 2019;25:1289-1309
  11. Tata G, Kisabay A, Gokcay F, Celebisoy N. Idiopathic intracranial hypertension: Are there predictors for visual outcome or recurrences? Clin Neurol Neurosurg 2019;183:105378
  12. Hilely A, Hecht I, Goldenberg-Cohen N, Leiba H. Long-term follow-up of pseudotumor cerebri syndrome in prepubertal children, adolescents, and adults. Pediatr Neurol 2019;101:57-63
  13. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-781
  14. Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 2014;54:1-11
  15. Mallery RM, Rehmani OF, Woo JH, et al. Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertens